5 Things You Should Know About Prostate Cancer Clinical Trials

0
(0)

5. Understand the Importance of Prostate Cancer Trials

The reasons for patients deciding to participate in clinical trials are individual and each person has their own different ones. However, understanding the importance of clinical trials to advance fields like prostate cancer may help patients decide. Prostate cancer clinical trials are determinant for the development of new medical treatments, but they’re also contributing to improving prostate cancer survival rates, continuing the evolution of fighting the disease, and for assuring efficacy and safety as well as for the approval of these therapies.

Read more about why clinical trials are necessary, what they are exactly, and how men with prostate cancer might benefit from clinical trials working to advance new therapies here.

 

Learn more about prostate cancer.

Prostate Cancer News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
×
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Latest Posts
  • NCCN and Rubraca
  • Orgovyx and FDA approval
  • Lynparza
  • Erleada results

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

One comment

  1. Brian Haselum says:

    I am currently receiving treatment for early metastatic prostate cancer. The treatment resulting from two recent trials, one in the USA Chaarted and one in the U.K. Stampede, using both Docetaxel and Goselerin . I am now halfway through the Chemotherapy 6 doses every three weeks and the first injection of Goselerin 4 weeks ago. I had a PSA test yesterday hopefully results are good

Leave a Comment

Your email address will not be published. Required fields are marked *